telmisartan
chemical compound
Facts
16 properties- Instance of
- type of chemical entity
- Subclass of
- chemical compound[5]
- Has use
- medication[6]
- Active ingredient in
- Kinzalmono, Micardis, Pritor, Telmisartan Actavis, Telmisartan Teva, Telmisartan Teva Pharma, Tolura
- Canonical SMILES
- CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C[3]
- Chemical formula
- C₃₃H₃₀N₄O₂[4]
- Defined daily dose
- 40 mg
- Legal status (medicine)
- boxed warning
- LiverTox likelihood score
- LiverTox toxicity likelihood category E*
- Mass
- 514.237 Da
- Medical condition treated
- arterial hypertension, congestive heart failure
- Physically interacts with
- angiotensin II receptor type 1[2]
- Pregnancy category
- Australian pregnancy category D, US pregnancy category D
- Significant drug interaction
- lisinopril dihydrate, quinapril, ramipril, captopril, enalapril, trandolapril, fosinopril, perindopril, trimethoprim, triamterene, amiloride, eplerenone[7][8][9][10][11][12][13][14][15][16][17][18][19][20]
+16 more
spironolactone, nabumetone, naproxen, celecoxib, Diclofenac, piroxicam, meloxicam, (RS)-fenoprofen, (±)-flurbiprofen, ibuprofen, indomethacin, (RS)-ketoprofen, (RS)-etodolac, sulindac, parecoxib, tenoxicam - Subject has role
- angiotensin II receptor antagonist, antihypertensive drug
- World Health Organisation international non-proprietary name
- telmisartan
🏷️ Also known as
en telmisartan
en Telmisartan
en 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
en 4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
en 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
en 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
en 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
en 4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
en 4'-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
en 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
en BIBR 277
en BIBR-277SE
en Micardis®
en Pritor®
ar تلميسارتان
el Τελμισαρτάνη
es Telmisartan
es Telmisartán
fa تلمیزارتان
fi telmisartaani
🔖 Identifiers · 41
- OpenAlex ID
- C2779716603
- ATC code
- C09CA07
- CAS Registry Number
- 144701-48-4
- ChEBI ID
- 9434
- ChEMBL ID
- CHEMBL1017
- ChemSpider ID
- 59391
- DSSTOX compound identifier
- DTXCID803636
- DSSTox substance ID
- DTXSID8023636
- DeCS ID
- 57617
- DrugBank ID
- DB00966
- DrugCentral ID
- 2583
- EC number
- 620-494-7
Show all 41 identifiers +29
- ECHA Substance Infocard ID
- 100.149.347
- Freebase ID
- /m/065xz3
- Guide to Pharmacology Ligand ID
- 592
- HSDB ID
- 7590
- Human Metabolome Database ID
- HMDB0015101
- InChIKey
- RMMXLENWKUUMAY-UHFFFAOYSA-N
- LiverTox ID
- Telmisartan
- MassBank accession ID
- SM819101, SM819151, MSBNK-Athens_Univ-AU225101, MSBNK-Athens_Univ-AU225102, MSBNK-Athens_Univ-AU225103, MSBNK-Athens_Univ-AU225104, MSBNK-Athens_Univ-AU225105, MSBNK-Athens_Univ-AU225107, MSBNK-Athens_Univ-AU225108, MSBNK-Athens_Univ-AU225109, MSBNK-Athens_Univ-AU225110, MSBNK-Athens_Univ-AU225111
+43 more
MSBNK-Athens_Univ-AU225130, MSBNK-Athens_Univ-AU225131, MSBNK-Athens_Univ-AU225132, MSBNK-Athens_Univ-AU225133, MSBNK-Athens_Univ-AU225151, MSBNK-Athens_Univ-AU225152, MSBNK-Athens_Univ-AU225153, MSBNK-Athens_Univ-AU225154, MSBNK-Athens_Univ-AU225155, MSBNK-Eawag-EA280501, MSBNK-Eawag-EA280502, MSBNK-Eawag-EA280503, MSBNK-Eawag-EA280504, MSBNK-Eawag-EA280505, MSBNK-Eawag-EA280506, MSBNK-Eawag-EA280507, MSBNK-Eawag-EA280508, MSBNK-Eawag-EA280509, MSBNK-Eawag-EA280510, MSBNK-Eawag-EA280511, MSBNK-Eawag-EA280512, MSBNK-Eawag-EA280513, MSBNK-Eawag-EA280514, MSBNK-Eawag-EA280551, MSBNK-Eawag-EA280552, MSBNK-Eawag-EA280553, MSBNK-Eawag-EA280554, MSBNK-Eawag-EA280555, MSBNK-Eawag-EA280556, MSBNK-Eawag-EA280558, MSBNK-Eawag-EA280559, MSBNK-Eawag-EA280560, MSBNK-Eawag-EA280561, MSBNK-Eawag-EA280562, MSBNK-Eawag-EA280563, MSBNK-Eawag-EA280564, MSBNK-UFZ-UA006301, MSBNK-UPAO-UPA00022, MSBNK-Waters-WA002327, MSBNK-Waters-WA002328, MSBNK-Waters-WA002329, MSBNK-Waters-WA002330, MSBNK-Waters-WA002331 - MeSH descriptor ID
- D000077333
- MeSH tree code
- D02.455.426.559.389.185.849, D03.633.100.103.791
- MedlinePlus drug identifier
- a601249
- Microsoft Academic ID (discontinued)
- 2779716603
- NDF-RT ID
- N0000148599
- NSC number
- 759811
- PDB ligand ID
- TLS
- PDB structure ID
- 3VN2
- Probes And Drugs ID
- PD000538
- PubChem CID
- 65999
- Reaxys registry number
- 6624054
- RxNorm CUI
- 73494
- SPLASH
- splash10-014i-0000090000-6187f6c1620a7c2b51b1, splash10-014i-0000090000-dc95af971f11219cb750, splash10-014j-0000690000-92f9c219585dd2f6abdd, splash10-002b-0091820000-b4160c5238973be1326b, splash10-03di-0000090000-219191b231632ae82938, splash10-03di-0002490000-d9a86d68a321494f4172, splash10-00li-0095500000-433f75bf696d30339ffe, splash10-000i-0093100000-d1a212009af2d2b6d576, splash10-000i-0093000000-dc77c406187bdc1b4750, splash10-0002-0000900000-81da14e51168bd40dbc8, splash10-014i-0000090000-e488353a2ab5a5ca95c8, splash10-014i-0000090000-45ac38d5e068041afc7f
+29 more
splash10-0002-0051930000-355f3efe4c799be31eee, splash10-004i-0091000000-0119ca397b44d63c12e1, splash10-004i-0190000000-c8f628b5d1752b565720, splash10-03fr-0290000000-e1a994dd22ac9af9bd71, splash10-014i-0000090000-79a32c207900b92a8001, splash10-014i-0000090000-522439ae25d7e43446e5, splash10-002b-0061930000-355af521f837490feefd, splash10-004i-0091000000-28e6d3e6afd2cee22baf, splash10-004i-0190000000-24d6dc729edb2e402cb5, splash10-03fr-0290000000-8ed1014ce3c441c09502, splash10-0002-0000900000-683d2b1a6727533bf2cc, splash10-014i-0000900000-2da316f976108d0ab57a, splash10-03di-0000090000-fa13ab012f6c3edda644, splash10-0fri-0094500000-fc4e746d5acf7c28974b, splash10-000i-0093000000-739535a2fb80154ac329, splash10-000i-0093000000-7b45a183400fc2d5c56e, splash10-0079-0090000000-f2b72bb436b094188b4b, splash10-03di-0000090000-4193d926fb43b7e7650a, splash10-00ri-0090400000-4c927fd317a9c571c8c1, splash10-000i-0094000000-a362fb77a1bf330b4d4b, splash10-0f79-0095000000-c9574b21fc223d1415ff, splash10-000i-0090000000-0d0b0eddab1ab829b1c1, splash10-00di-0090000000-95cf0efe8a365f6e1b11, splash10-014i-0000900000-3c8f5cf8f5d9a897d72d, splash10-014j-0000690000-e5484f50567b0ed1d402, splash10-014i-0011390000-909e49aea97bff3f66e6, splash10-0bt9-2596000000-b809729f5d533c915b79, splash10-016r-0081290000-363d23081a66306a3f9e, splash10-01p9-0093450000-1dd7fd500cf0b3c0dc32 - SureChEMBL ID
- 4464
- UMLS CUI
- C0248719
- UNII
- U5SYW473RQ
- UNSPSC code
- 51121763
- UniChem compound ID
- 107994
- WikiProjectMed ID
- Telmisartan
🔗 Connections
Significant drug interaction 87
← Significant drug interaction 87
Subject has role 2
Belongs to 1
Has use 1
Legal status (medicine) 1
Medical condition treated 1
Subclass of 1
← Drug or therapy used for treatment 1
← FactGrid item ID 1
Press Enter · cited answer in seconds
0 sources
Summary
telmisartan is a type of chemical entity[1].